Vir Biotechnology Inc’s filing revealed that its Chief Executive Officer De Backer Marianne unloaded Company’s shares for reported $0.69 million on Apr 03 ’24. In the deal valued at $9.46 per share,72,995 shares were sold. As a result of this transaction, De Backer Marianne now holds 678,457 shares worth roughly $6.93 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, HANLY ANN M. sold 2,711 shares, generating $27,251 in total proceeds. Upon selling the shares at $10.05, the EVP & Chief Technology Officer now owns 132,069 shares.
Before that, Lee Sung sold 6,008 shares. Vir Biotechnology Inc shares valued at $59,404 were divested by the EVP & Chief Financial Officer at a price of $9.89 per share. As a result of the transaction, Lee Sung now holds 100,492 shares, worth roughly $1.03 million.
JP Morgan downgraded its Vir Biotechnology Inc [VIR] rating to a Neutral from a an Overweight in a research note published on January 29, 2024; the price target was decreased to $9 from $23. A number of analysts have revised their coverage, including BofA Securities’s analysts, who decreased its forecast for the stock in early September from “a Buy” to “a Neutral”. JP Morgan also remained covering VIR and has increased its forecast on March 06, 2023 with a “an Overweight” recommendation from previously “Neutral” rating. Goldman revised its rating on February 21, 2023. It rated VIR as “a Buy” which previously was an “a Neutral”.
Price Performance Review of VIR
On Tuesday, Vir Biotechnology Inc [NASDAQ:VIR] saw its stock jump 5.37% to $10.21. Over the last five days, the stock has gained 1.29%. Vir Biotechnology Inc shares have risen nearly 1.49% since the year began. Nevertheless, the stocks have fallen -59.71% over the past one year. While a 52-week high of $27.48 was reached on 02/27/24, a 52-week low of $7.61 was recorded on 04/25/24. SMA at 50 days reached $9.47, while 200 days put it at $9.93. A total of 0.88 million shares were traded, compared to the trading of 0.57 million shares in the previous session.
Levels Of Support And Resistance For VIR Stock
The 24-hour chart illustrates a support level at 9.76, which if violated will result in even more drops to 9.31. On the upside, there is a resistance level at 10.50. A further resistance level may holdings at 10.80. The Relative Strength Index (RSI) on the 14-day chart is 60.90, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.04, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 20.60%. Stochastics %K at 67.98% indicates the stock is a holding.
